l 158809 has been researched along with captopril in 12 studies
| Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) | Studies (captopril) | Trials (captopril) | Recent Studies (post-2010) (captopril) |
|---|---|---|---|---|---|
| 137 | 0 | 7 | 10,320 | 1,514 | 890 |
| Protein | Taxonomy | l 158809 (IC50) | captopril (IC50) |
|---|---|---|---|
| Leukotriene A-4 hydrolase | Homo sapiens (human) | 3.6 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.084 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0173 | |
| Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | 3.3 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.1004 | |
| Beta-lactamase | Pseudomonas aeruginosa | 5 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.011 | |
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, DY; DeWitt, BJ; Kadowitz, PJ; McMahon, TJ | 1 |
| Bonsib, SM; Cohen, EP; Fish, BL; Moulder, JE | 1 |
| Fogo, A; Ichikawa, I; Patel, A; Peten, EP; Striker, GE; Striker, LJ | 1 |
| Fogo, A; Freeman, M; Lo, W; Oikawa, T; Vaughan, DE | 1 |
| Cohen, EP; Fish, BL; Moulder, JE | 2 |
| Cohen, EP; Fish, BL; Molteni, A; Moulder, JE; Taylor, JM; Veno, PA; Ward, WF; Wolfe, LF | 1 |
| Tikkanen, I; Uhlenius, N; Vuolteenaho, O | 1 |
| Miettinen, A; Tikkanen, I; Uhlenius, N; Vuolteenaho, O | 1 |
| Anderson, D; Granger, JP; Klett, CP; Sholook, M | 1 |
| Hyjek, E; Jaggi, JS; McDevitt, MR; Scheinberg, DA; Seshan, SV; Sgouros, G | 1 |
| Celik, HA; Ilter, T; Nart, D; Oruc, N; Ozutemiz, O; Yuce, G | 1 |
12 other study(ies) available for l 158809 and captopril
| Article | Year |
|---|---|
Comparison of pressor responses to angiotensin I, II, and III in pulmonary vascular bed of cats.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Captopril; Cats; Female; Imidazoles; Male; Pulmonary Circulation; Tetrazoles | 1994 |
Angiotensin II receptor antagonists in the prevention of radiation nephropathy.
Topics: Angiotensin Receptor Antagonists; Animals; Captopril; Imidazoles; Kidney; Male; Radiation-Protective Agents; Rats; Tetrazoles; Whole-Body Irradiation | 1996 |
The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice.
Topics: Actins; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; Blood Pressure; Body Weight; Captopril; Collagen; Collagenases; Creatinine; Disease Models, Animal; Extracellular Matrix; Gelatinases; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Growth Hormone; Imidazoles; Juxtaglomerular Apparatus; Kidney; Kidney Glomerulus; Lymphotoxin-alpha; Mice; Mice, Transgenic; Muscle, Smooth; Organ Size; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Thymidine | 1994 |
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cytokines; Enalapril; Fibrin; Fibrinolysin; Fibrosis; Gene Expression Regulation, Enzymologic; Growth Substances; Imidazoles; In Situ Hybridization; Kidney; Male; Plasminogen Activator Inhibitor 1; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Tetrazoles; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 1997 |
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Imidazoles; Kidney; Kidney Diseases; Kidney Function Tests; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Survival Rate; Tetrazoles; Time Factors; Treatment Outcome | 1998 |
Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bone Marrow Transplantation; Captopril; Imidazoles; Kidney; Lung; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Renal Insufficiency; Renin-Angiotensin System; Tetrazoles | 1998 |
Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bone Marrow Transplantation; Captopril; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Fibrosis; Imidazoles; Kidney Diseases; Male; Radiotherapy; Rats; Tetrazoles; Time Factors | 2001 |
Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Autoradiography; Blood Pressure; Captopril; Cyclic GMP; Enzyme Inhibitors; Female; Hypertension, Renal; Imidazoles; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Tetrazoles | 2001 |
Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Autoradiography; Blood Pressure; Body Weight; Captopril; Drinking; Enzyme Inhibitors; Female; Glomerulonephritis; Glomerulonephritis, Membranous; Imidazoles; Kidney; Kidney Failure, Chronic; Microscopy, Fluorescence; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Tetrazoles | 2002 |
Antisense oligodeoxynucleotides directed against a novel angiotensinogen mRNA-stabilizing protein reduce blood pressure in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Hypertension; Imidazoles; Liver; Male; Oligonucleotides, Antisense; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA Stability; RNA, Messenger; Tetrazoles | 2004 |
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
Topics: Actinium; Alpha Particles; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Female; Imidazoles; Kidney; Kidney Tubules; Mice; Mice, Inbred BALB C; Mineralocorticoid Receptor Antagonists; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Spironolactone; Tetrazoles | 2006 |
Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target?
Topics: Amylases; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Ceruletide; Disease Models, Animal; Imidazoles; Injections, Intraperitoneal; Male; Neutrophil Infiltration; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Rats; Rats, Wistar; Renin-Angiotensin System; Taurocholic Acid; Tetrazoles; Treatment Outcome | 2010 |